Ipilimumab plus nivolumab for advanced melanoma.
Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg 69120, Germany. Electronic address: jessica.hassel@med.uni-heidelberg.de.
Jessica C
JC
Hassel
D000911:Antibodies, Monoclonal; D006801:Humans; D000074324:Ipilimumab; D008545:Melanoma; D000077594:Nivolumab
D000911:Antibodies, Monoclonal; D000074324:Ipilimumab; D000077594:Nivolumab